Summary: This week we delve into the world of heart failure and transplantation and review a recent report from the ACTION Network about the use of the Heartmate 3 VAD for young patients. Does this device offer advantages over prior durable VAD's? What are the patient size limitations for such a device? Why might this device have fewer complications than prior devices? Dr. Matthew O'Connor, Assistant Professor of Pediatrics at The University of Pennsylvania shares his deep insights with us this week. doi: 10.1016/j.healun.2020.02.007.
